Recent and notable ECNP press releases
Below you can find a list of the most important ECNP press releases in chronological order.
3 September 2024
Karlijn Kooij wins the 2024 Best Negative Data Prize in Preclinical Neuroscience
21 May 2024
Elias Eriksson wins 2024 ECNP Neuropsychopharmacology Award
1 April 2024
2024 Best Negative Data Prize in Pre-Clinical Neuroscience: call for submissions
7 December 2023
First international expert and patient collaboration recommends changes to development, assessment, and approval of mental health medicines for young people
20 April 2023
Oscar Marín wins 2023 ECNP Neuropsychopharmacology Award
30 March 2023
Cohen Veterans Bioscience (CVB) and ECNP announce the opening of submissions for the 2023 Best Negative Data Prize in Clinical Neuroscience
15 December 2022
Common psychiatric drugs appear to reduce effect of Covid-19
31 August 2022
Most promising PTSD treatment may use ‘ecstasy’ or ‘magic mushrooms’ alongside psychotherapy
16 June 2022
Marie Åsberg wins 2022 ECNP Neuropsychopharmacology Award
15 March 2022
2022 Best Negative Data Prize: call for applications
25 May 2021
Valery Grinevich wins 2021 ECNP Neuropsychopharmacology Award
17 February 2021
Most European countries ignore patients with severe mental illness in COVID vaccine strategy despite significant risks
View infographics here.
29 May 2020
SSRI antidepressants associated with increase in violent crime in some patients
5 May 2020
Markus Heilig wins 2020 ECNP Neuropsychopharmacology Award
4 January 2020
How diet affects mental health –what’s the evidence?
11 June 2019
Inga Neumann wins 2019 ECNP Neuropsychopharmacology Award
6 March 2019
Scientists unveil plans to identify common social and cognitive elements in patients with Alzheimer’s disease, Depression, Schizophrenia
To discover more about the PRISM project, click here.
2 October 2018
Why do some get depressed and others don’t? Clues from the “winter blues”
26 March 2018
Marion Leboyer wins 2018 ECNP Neuropsychopharmacology Award
8 November 2017
World’s first prize for “negative” scientific results announced
1 April 2017
Michel Hamon wins 2017 ECNP Neuropsychopharmacology Award
6 March 2017
Scientists show cognitive enhancing drugs can improve chess play
30 November 2016
Study suggests prescribing of baclofen for alcohol dependence “should be reconsidered”
13 April 2016
Major mental health project aims to uncover root causes of social withdrawal
20 August 2015
Systematic review shows ‘smart drug’ modafinil does enhance cognition
July 2015
ECNP special news feature: interview Tom Insel
3 July 2015
Mary Baker wins the 2015 ECNP Media Award
23 March 2015
Francesc Artigas’s exceptional research contributions to depression and schizophrenia recognised by the 2015 ECNP Neuropsychopharmacology Award
November 2013
Ex ECNP President David Nutt wins the 2013 John Maddox Prize for standing up for science
Spring 2013
International collaboration to address new approach to psychiatric drug nomenclature
Joseph Zohar, President of the ECNP
8 May 2012
The Science Media Centre, London, wins the 2012 ECNP Media Award
5 September 2011
The Size and Burden of Mental Disorders in Europe
Read the press release
Reactions to the report:
14 June 2011
Funding crisis threatens development of new treatments for mental illness
For the full press release in English, click here.
The full press release can also be read in French, in German and in Spanish.
On 14 June ECNP released the report, prepared by David Nutt and Guy Goodwin, of its Summit meeting of key European neuroscience stakeholders on the future of CNS drug research in Europe.
Reactions to the report:
